Less Ads, More Data, More Tools Register for FREE

Transaction in Own Shares

30 Oct 2012 07:00

RNS Number : 7849P
Origo Partners PLC
30 October 2012
 



30 October 2012

Origo Partners PLC

Transaction in Own Shares 

Origo Partners ("Origo" or the "Company") today announces that the Board has authorised a share buyback programme of up to US$1.5 million. Ordinary shares in the Company will be repurchased at prices below the estimated Net Asset Value per share. The buyback programme is limited to a time frame of three months from the date of authorisation.

In the context of the Company's current focus on prudent management of the existing portfolio and cash reserves, the Board believes that a limited programme of purchasing shares at a discount to NAV will benefit the remaining shareholders.

Purchased shares will be cancelled by the Company and shares will not carry voting or dividend distribution rights.

 

For further information about Origo please visit www.origoplc.com or contact:

Origo Partners plc

Chris Rynning

(chris@origoplc.com)

Niklas Ponnert

(niklas@origoplc.com)

 

 

 

Nominated Advisor & Broker

Liberum Capital Limited

Simon Atkinson/Richard Bootle

 

+44 (0)20 3100 2222

Public Relations:

Aura Financial

Nina Legge

+44 (0)20 7321 0000

 

Notes to editors:

Origo is an AIM-listed private equity investor and strategic consultancy business which provides its shareholders with exposure to China-linked investment opportunities.

 

Origo has a significant portfolio of investments in a range of industrial sectors, including metals and mining, agriculture, renewable energy/clean-tech and technology, telecom and media.

 

Origo invests directly in high growth Chinese companies as well as in companies based around the world with significant exposure to Chinese export markets.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
POSFEIFIUFESELS

Related Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Back to RNS